(Q33597429)

28 July 2017

The effects of discontinuing cinacalcet at the time of kidney transplantation (English)

1 reference

28 July 2017

kidney transplantation

1 reference

Michel Jadoul

1

1 reference

28 July 2017

Ana Baños

series ordinal

2

1 reference

28 July 2017

Valter J Zani

series ordinal

3

1 reference

28 July 2017

Gavril Hercz

series ordinal

4

1 reference

28 July 2017

4 December 2009

1 reference

28 July 2017

1 reference

28 July 2017

3

1 reference

28 July 2017

1

1 reference

28 July 2017

37-41

1 reference

Creative Commons Attribution-NonCommercial 2.5 Generic

28 July 2017

start time

3 October 2016

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

The OPTIMA study: assessing a new cinacalcet (Sensipar/Mimpara) treatment algorithm for secondary hyperparathyroidism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2808133

Prediction of creatinine clearance from serum creatinine

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2808133

Preliminary experience with cinacalcet use in persistent secondary hyperparathyroidism after kidney transplantation

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2808133

Hypercalcemia due to resistant hyperparathyroidism in renal transplant patients treated with the calcimimetic agent cinacalcet.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2808133

Effective control of persistent hyperparathyroidism with cinacalcet in renal allograft recipients.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2808133

Early and severe hyperparathyroidism associated with hypercalcemia after renal transplant treated with cinacalcet.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2808133

The calcimimetic cinacalcet normalizes serum calcium in renal transplant patients with persistent hyperparathyroidism

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2808133

Successful treatment of hypercalcemia with cinacalcet in renal transplant recipients with persistent hyperparathyroidism

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2808133

Cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in hemodialysis and peritoneal dialysis: a randomized, double-blind, multicenter study

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2808133

Achieving NKF-K/DOQI bone metabolism and disease treatment goals with cinacalcet HCl.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2808133

Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2808133

Natural history of parathyroid function and calcium metabolism after kidney transplantation: a single-centre study

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2808133

Cinacalcet chloride is efficient and safe in renal transplant recipients with posttransplant hyperparathyroidism

30 October 2018

1 reference

12 December 2020

Improvement in hypercalcemia with cinacalcet after kidney transplantation

1 reference

12 December 2020

Sequential changes in vitamin D and calcium metabolism after successful renal transplantation

1 reference

12 December 2020

Long-term evolution of renal osteodistrophy after renal transplantation

1 reference

12 December 2020

Cinacalcet HCI (Sensipar/Mimpara) is an effective chronic therapy for hemodialysis patients with secondary hyperparathyroidism

1 reference

12 December 2020

Treatment of severe hypercalcemia due to refractory hyperparathyroidism in renal transplant patients with the calcimimetic agent cinacalcet

1 reference

12 December 2020

Identifiers

DOI

10.1093/NDTPLUS/SFP167

1 reference

28 July 2017

1 reference

28 July 2017

1 reference